Association between chlamydia pneumoniae infection and carotid atherosclerotic plaques

Journal of Research in Medical Sciences

Volumn 12, Issue 4, 2007, Pages 165-171

  Ashtari, Fereshteh ^a   Saberi, Alia ^a   Shayegannejad, Vahid ^a   Khosravi, Alireza ^a   Sherkat, Roya ^a   Khosravi, Elham ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerotic plaque; Chlamydia pneumoniae; Serum antibody

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 34548625596     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Biller J, Love BB. Vascular diseases of the nervous system: Ischemic cerebrovascular diseases. In: Bradley WE, Daroff RB, Fenichel GM, Jankovic J, editors. Neurology in clinical practice. 4 ed. Boston: Butterworth Heinemann; 2004. 1219.
2. Jackson LA, Grayston JT. Chlamydia pneumoniae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Disease. 5 ed. Philadelphia: Churchill Livingstone; 2000. 2011-2012.
3. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64(5):359-362.
4. Monno R, Di Biase M, Costi A, de Nicolo T, Correale M, Bolognese P et al. [Chlamydia pneumoniae, atherosclerosis, and coronary disease]. Ital Heart J Suppl 2003; 4(5):383-397.
5. Nikoskelainen J, Kalliomaki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand 1983; 214(1):29-32.
6. Tanne D, Haim M, Boyko V, Goldbourt U, Reshef T, Adler Y et al. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis 2003; 16(2): 166-170.
7. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active Coxsackie virus B infection. Am Heart J 1975; 89(3):283-287.
8. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32(4):855-860.
9. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998; 26(3):719-734.
10. Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 2001; 32(9):1973-1976.
11. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 2002; 106(19):2428-2433.
12. Babikian VL, Tegeler CH. Ultrasound imaging of the cerebral vasculature. In: Bradley WE, Daroff RB, Fenichel GM, Jankovic J, editors. Neurology in clinical practice. 4 ed. Boston: Butterworth Heinemann; 2004. 651.
13. Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9(3):303-306.
14. Medrano V, Castano MD, Andreu M, Molto JM, Sanchez-Perez RM, Hernandez-Lorido R et al. [The relation between carotid ultrasound changes and seropositivity to Chlamydia pneumoniae in patients with acute stroke]. Rev Neurol 2000; 31(10):932-936.
15. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29(2):404-410.
16. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000; 31 (7): 1521-1525.
17. Wolf SC, Mayer O, Jurgens S, Vonthein R, Schultze G, Risler T et al. Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003; 59(4):273-279.
18. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27(12):2207-2210.
19. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006; 37(2):482-486.
20. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116(4):273-278.
21. Gerdes VE, Verkooyen RP, Kwa VI, de Groot E, van Gorp EC, Ten Cate H et al. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 2003; 167(1):65-71.
22. Colpan ME, Attar A, Colpan A, Karahan C, Seckin S, Sargon MF et al. Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis. J Clin Neurosci 2004; 11 (4):389-394.
23. Kawamoto R, Kajiwara T, Oka Y, Takagi Y. An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese. Intern Med 2003; 42(7):571-575.
24. Anzini A, Cassone A, Rasura M, Ciervo A, Beccia M, Di Lisi F et al. Chlamydia pneumoniae infection in young stroke patients: a case - control study. Eur J Neurol 2004; 11(5):321-327.
25. Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003; 15(1-2): 11-16.
26. Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med 1997; 45(4): 168-174.
27. Lehr HA, Sagban TA, Kirkpatrick CJ. [Atherosclerosis-progression by nonspecific activation of the immune system]. Med Klin (Munich) 2002; 97(4):229-235.
28. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137(5):1532-1537.
29. Valtonen W. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 23(5):539-543.
30. Rupp J, Berger M, Reiling N, Gieffers J, Lindschau C, Haller H et al. Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression. Biochem Biophys Res Commun 2004; 320(3):738-744.
31. Kazmierski R, Kozubski W. [Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development]. Neurol Neurochir Pol 2002; 36(1):131-142.
32. Muhlestein JB. Bacterial infections and atherosclerosis. J Investig Med. 1998; 46(8):396-402.
33. Haynes BF, Fauci AS. Disorders of immune system, connective tissue, and joints. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Lonco DL, Jameson JL, editors. Harrison principles of internal medicine. 15 ed. New York: McGraw-Hill; 2001.1805-2018.
34. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25(5): 1045-1050.
35. Saito I, Mori M, Shibata H, Hirose H, Tsujioka M, Kawabe H. Prevalence of metabolic syndrome in young men in Japan. J Atheroscler Thromb 2007; 14(1):27-30.
36. Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A. Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb 2007; 14(1):36-43.